 |
| |
| May-14-18 09:53PM | ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2018 GlobeNewswire +26.76% |
| May-07-18 07:30PM | PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND GlobeNewswire |
| Mar-21-18 09:06AM | ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017 GlobeNewswire |
| 09:00AM | ProPhase Labs, Inc. to Host Earnings Call ACCESSWIRE |
| Mar-16-18 10:23AM | ProPhase Labs to Release Fiscal 2017 Results on Wednesday, March 21st GlobeNewswire |
| Feb-20-18 07:15PM | ProPhase Labs, Inc. Announces New Compensatory Arrangement With Chief Executive Officer and Termination of Stockholder Rights Plan GlobeNewswire |
| Dec-22-17 08:00AM | ProPhase completes $4.5M tender offer American City Business Journals |
| Dec-21-17 04:00PM | ProPhase Labs, Inc. Announces Final Results of Its Tender Offer GlobeNewswire |
| Dec-19-17 04:30PM | ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer GlobeNewswire |
| Nov-30-17 05:25PM | Can ProPhase Labs Inc (PRPH) Continue To Outperform Its Industry? Simply Wall St. |
| Nov-24-17 08:48AM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017 Capital Cube |
| Nov-20-17 08:30PM | ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 1.7 Million Shares of Its Common Stock at Price of $2.30 Per Share GlobeNewswire |
| Nov-13-17 08:30AM | ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017 GlobeNewswire |
| Nov-10-17 08:00AM | Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock GlobeNewswire |
| Oct-03-17 12:46PM | Is ProPhase Labs Inc (PRPH) A Buy At Its Current Price? Simply Wall St. |
| Sep-29-17 08:30AM | ProPhase Labs, Inc. Announces Final Results of Its Tender Offer GlobeNewswire |
| Sep-26-17 04:05PM | ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer GlobeNewswire |
| Aug-25-17 04:05PM | ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 4.0 Million Shares of Its Common Stock at Price of $2.30 Per Share GlobeNewswire |
| Aug-17-17 11:11AM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017 Capital Cube |
| Aug-15-17 08:00PM | ProPhase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 4,000,000 Shares of Its Common Stock GlobeNewswire |
| Aug-11-17 08:00AM | ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2017 GlobeNewswire |
| Jun-13-17 04:30PM | ProPhase Labs Repurchases 1,061,980 Shares of Its Common Stock Marketwired |
| May-17-17 09:04AM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 17, 2017 Capital Cube |
| May-15-17 08:30AM | ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2017 Marketwired |
| Apr-05-17 04:10PM | ProPhase Provides Shareholder Update Marketwired |
| Mar-30-17 10:50AM | $50M deal done: Cold-Eeze has a new owner at bizjournals.com |
| 10:50AM | $50M deal done: Cold-Eeze has a new owner American City Business Journals |
| Mar-29-17 05:05PM | PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit |
| 04:30PM | ProPhase Labs, Inc. Completes Sale of Cold-EEZE(R) Business to Mylan Marketwired |
| Mar-13-17 12:11PM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017 Capital Cube |
| Mar-09-17 02:03PM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: 2016 By the Numbers : March 9, 2017 Capital Cube |
| Mar-02-17 01:04PM | PROPHASE LABS, INC. Financials |
| Feb-27-17 04:08PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 08:00AM | ProPhase Labs Reports Financial Results for the Year Ended December 31, 2016 Marketwired |
| Feb-24-17 04:09PM | PROPHASE LABS, INC. Files SEC form 10-K, Annual Report |
| Jan-13-17 09:06AM | Mylans Recent Commercial and Product Developments |
| Jan-10-17 06:34AM | Pharmaceutical company to sell Cold-Eeze lozenge brand |
| 06:34AM | Pharmaceutical company to sell Cold-Eeze lozenge brand Associated Press |
| Jan-09-17 02:21PM | PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights o |
| 09:12AM | $50M deal: Bucks County firm selling Cold-Eeze brand at bizjournals.com |
| 09:12AM | $50M deal: Bucks County firm selling Cold-Eeze brand American City Business Journals |
| 08:51AM | Mylan Expands OTC Offerings by Acquiring Cold-Eeze TheStreet.com |
| 07:35AM | ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM Marketwired |
| 07:30AM | ProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE(R) Brand Marketwired |
| Nov-23-16 10:50AM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 |
| Nov-17-16 08:20AM | PROPHASE LABS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| Nov-16-16 04:30PM | ProPhase Labs Reports Arbitration Decision In Phusion Laboratories/Phosphagenics Dispute Marketwired |
| Nov-15-16 03:14PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 03:08PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report |
| Nov-14-16 08:00AM | ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2016 Marketwired |
| Aug-11-16 12:30PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report +17.86% |
| 11:29AM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 |
| Aug-10-16 06:10AM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib +12.07% |
| Aug-09-16 06:15PM | ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2016; Exploring Strategic Alternatives to Enhance Shareholder Value Marketwired |
| 07:07AM | Q2 2016 ProPhase Labs Inc Earnings Release - After Market Close |
| Aug-05-16 12:11PM | ProPhase Labs to Release Second Quarter 2016 Results on Tuesday, August 9th Marketwired |
| Jun-01-16 02:36PM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 |
| May-26-16 06:08AM | PROPHASE LABS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders |
| May-13-16 01:08PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report |
| May-11-16 05:27PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| May-10-16 04:10PM | ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2016 Marketwired |
| Apr-11-16 12:39PM | Edited Transcript of PRPH earnings conference call or presentation 29-Mar-16 3:00pm GMT |
| Apr-07-16 10:00AM | ProPhase Labs (Nasdaq: PRPH) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire |
| Mar-30-16 01:33PM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q4, 2015 By the Numbers |
| 12:08PM | ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: 2015 By the Numbers |
| Mar-29-16 02:18PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 02:17PM | PROPHASE LABS, INC. Files SEC form 10-K, Annual Report |
| 01:27PM | ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 at noodls |
| 09:55AM | ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 Marketwired |
| 07:07AM | Q4 2015 ProPhase Labs Inc Earnings Release - Before Market Open |
| Mar-28-16 12:59PM | ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th at noodls |
| Mar-25-16 08:00AM | ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th Marketwired |
| Jan-15-16 06:05AM | PROPHASE LABS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| Jan-13-16 06:47PM | ProPhase Labs Discusses the Current Cold Season and Announces Launch of New Product Line, TK Supplements Marketwired |
| Dec-16-15 04:32PM | PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob |
| Dec-07-15 11:31AM | ProPhase Labs, Inc. Earnings Analysis: Q3, 2015 By the Numbers |
| Nov-13-15 01:01PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statem |
| 12:08PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report |
| Nov-12-15 08:00AM | ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2015 Marketwired |
| Sep-17-15 11:02AM | ProPhase Labs, Inc. (Nasdaq:PRPH) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire |
| Sep-04-15 11:47AM | ProPhase Labs, Inc. Earnings Q2, 2015 |
| Aug-14-15 08:10PM | 10-Q for ProPhase Labs, Inc. at Company Spotlight |
| Aug-13-15 06:05AM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| Aug-12-15 03:32PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report |
| 08:00AM | ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2015 Marketwired |
| Aug-05-15 12:55PM | ProPhase Establishes 3.2 Million Share Equity Line Marketwired |
| 12:37PM | PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur |
| Jul-06-15 04:21PM | PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| Jun-19-15 10:33AM | PROPHASE LABS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Submission of Matters to |
| Jun-01-15 06:04AM | PROPHASE LABS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| May-28-15 01:32PM | Seasonal Businesses Sweat Year-Round To Shine On Time at Investor's Business Daily |
| May-27-15 11:08AM | PROPHASE LABS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar |
| May-15-15 08:09PM | 10-Q for ProPhase Labs, Inc. at Company Spotlight |
| May-13-15 04:31PM | PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib |
| 04:24PM | PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report |
| 04:10PM | ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2015 Marketwired |
| Apr-29-15 08:15PM | 10-K for ProPhase Labs, Inc. at Company Spotlight |
| Apr-17-15 04:22PM | PROPHASE LABS, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| Apr-02-15 10:19AM | ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014 at noodls |
| Mar-27-15 01:10PM | PROPHASE LABS, INC. Files SEC form 10-K, Annual Report |
|
|
|
|
| ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Karkus Ted William | CEO & CHAIRMAN | May 15 | Option Exercise | 1.86 | 250,000 | 465,000 | 2,704,574 | May 17 12:40 PM | | Karkus Ted William | CEO & CHAIRMAN | Dec 21 | Sale | 2.30 | 424,789 | 977,015 | 2,484,849 | Dec 26 03:02 PM | | Karkus Ted William | CEO & CHAIRMAN | Dec 14 | Option Exercise | 1.00 | 600,000 | 600,000 | 2,909,638 | Dec 18 04:00 PM | | Leonard Braden Michael | 10% Owner | Sep 29 | Sale | 2.30 | 1,695,305 | 3,899,202 | 627,322 | Oct 02 03:04 PM | | Barr Jason Michael | Director | Sep 29 | Sale | 2.30 | 4,379 | 10,072 | 7,721 | Oct 02 12:56 PM | | Karkus Ted William | CEO & CHAIRMAN | Sep 29 | Sale | 2.30 | 364,950 | 839,385 | 2,309,638 | Oct 02 12:53 PM | | CUDDIHY ROBERT V JR | Chief Financial Officer | Sep 29 | Sale | 2.30 | 358,621 | 824,828 | 132,703 | Oct 02 12:54 PM | | CUDDIHY ROBERT V JR | Chief Financial Officer | Sep 14 | Option Exercise | 1.26 | 360,000 | 453,600 | 491,324 | Sep 15 04:40 PM |
|
|
|
|
|
|
